These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7744980)

  • 21. [Treatment recommendations for various stages in diabetic nephropathy].
    Takane H; Suzuki H
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():379-83. PubMed ID: 15999738
    [No Abstract]   [Full Text] [Related]  

  • 22. Investigational drugs for diabetic nephropathy.
    Cortinovis M; Cattaneo D; Perico N; Remuzzi G
    Expert Opin Investig Drugs; 2008 Oct; 17(10):1487-500. PubMed ID: 18808309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Microalbuminuria as a warning sign of diabetic nephropathy. Test your diabetics early!].
    Dietrich W; Blumenstein M
    MMW Fortschr Med; 2003 Mar; 145(10):40-2. PubMed ID: 12688026
    [No Abstract]   [Full Text] [Related]  

  • 24. Should all diabetic patients take ACE inhibitors, even those without proteinuria?
    Hoogwerf BJ
    Cleve Clin J Med; 1999 Apr; 66(4):208-9. PubMed ID: 10199056
    [No Abstract]   [Full Text] [Related]  

  • 25. [The treatment of diabetic nephropathy. The need for an early diagnosis].
    Teruel Briones JL
    Rev Clin Esp; 1999 Jan; 199(1):1-3. PubMed ID: 10089768
    [No Abstract]   [Full Text] [Related]  

  • 26. Diabetic nephropathy--the family physician's role.
    Roett MA; Liegl S; Jabbarpour Y
    Am Fam Physician; 2012 May; 85(9):883-9. PubMed ID: 22612183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Renal histopathology of diabetic nephropathy].
    Suzuki Y
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():314-9. PubMed ID: 15999726
    [No Abstract]   [Full Text] [Related]  

  • 28. Renoprotective role of ACE inhibitors in diabetic nephropathy.
    Mogensen CE
    Br Heart J; 1994 Sep; 72(3 Suppl):S38-45. PubMed ID: 7946802
    [No Abstract]   [Full Text] [Related]  

  • 29. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
    Crook ED; Preddie DC
    Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Early diagnosis of and therapy for patients with diabetic nephropathy].
    Makino H
    Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):471-6. PubMed ID: 15052805
    [No Abstract]   [Full Text] [Related]  

  • 31. Controversies on the prevention of diabetic nephropathy.
    Chiarelli F; Verrotti A; Basciani F; di Ricco L; Sabatino G; Morgese G
    J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():365-9. PubMed ID: 9642666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
    Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diabetic nephropathy].
    Koya D; Kashiwagi A
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():625-9. PubMed ID: 15779451
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of angiotensin II antagonism in type 2 diabetes mellitus: a review of renoprotection studies.
    Zanella MT; Ribeiro AB
    Clin Ther; 2002 Jul; 24(7):1019-34. PubMed ID: 12182249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolving strategies for renoprotection: diabetic nephropathy.
    Parving HH; Hovind P; Rossing K; Andersen S
    Curr Opin Nephrol Hypertens; 2001 Jul; 10(4):515-22. PubMed ID: 11458033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise?
    Boel E; Selmer J; Flodgaard HJ; Jensen T
    J Diabetes Complications; 1995; 9(2):104-29. PubMed ID: 7599349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in renal outcomes with ACE inhibitors in type 1 and type 2 diabetic patients: possible explanations.
    Jerums G
    Miner Electrolyte Metab; 1998; 24(6):423-37. PubMed ID: 9930382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of early diabetic nephropathy.
    Molitch ME
    Am J Med; 1997 Apr; 102(4):392-8. PubMed ID: 9217622
    [No Abstract]   [Full Text] [Related]  

  • 39. Detecting and controlling diabetic nephropathy: what do we know?
    Appel G
    Cleve Clin J Med; 2013 Apr; 80(4):209-17. PubMed ID: 23547091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus.
    Goa KL; Haria M; Wilde MI
    Drugs; 1997 Jun; 53(6):1081-105. PubMed ID: 9179532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.